Sionna Therapeutics, Inc.
SION
$37.17
-$0.15-0.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -75.27M | -70.68M | -75.84M | -66.32M | -61.69M |
| Total Depreciation and Amortization | 647.00K | 662.00K | 642.00K | 661.00K | 668.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.98M | 7.78M | 13.97M | 12.17M | 11.31M |
| Change in Net Operating Assets | -2.65M | 786.00K | -2.69M | -2.41M | -3.08M |
| Cash from Operations | -66.30M | -61.45M | -63.91M | -55.90M | -52.79M |
| Capital Expenditure | -377.00K | -200.00K | -113.00K | -113.00K | -27.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -118.37M | -125.91M | -138.69M | -144.07M | -126.89M |
| Cash from Investing | -118.75M | -126.11M | -138.80M | -144.18M | -126.91M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 206.02M | 204.39M | 202.49M | 202.53M | 141.00K |
| Repurchase of Common Stock | -312.00K | -312.00K | -312.00K | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 0.00 | 181.33M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.43M | -2.50M | -2.50M | -2.50M |
| Cash from Financing | 205.71M | 202.64M | 199.67M | 200.02M | 178.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.66M | 15.08M | -3.04M | -57.00K | -733.00K |